This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Smithkline Beecham Corporation. Active years: 2003-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2006
Title: Peter John Lovell: Innovator in Pharmaceutical Compounds
Introduction
Peter John Lovell is a notable inventor based in Harlow, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of 2 patents, Lovell's work has had a meaningful impact on medical science.
Latest Patents
Lovell's latest patents include groundbreaking work on compounds of formula (I) wherein X is O, CH, S, or NH, or the moiety X—Ris hydrogen. His research also covers sulfonamide derivatives as 5-HT7 receptor antagonists. These inventions are crucial for advancing therapeutic options in various medical conditions.
Career Highlights
Peter John Lovell is associated with Smithkline Beecham Corporation, where he has been instrumental in research and development. His expertise in pharmaceutical compounds has positioned him as a key player in the industry.
Collaborations
Lovell has collaborated with esteemed colleagues such as David Kenneth Dean and Andrew Kenneth Takle. These partnerships have fostered innovation and enhanced the quality of research in their field.
Conclusion
Peter John Lovell's contributions to pharmaceutical innovations through his patents and collaborations highlight his importance in the industry. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile